1,481
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical characteristics and prognostic factors of 75 cases with acquired hemophagocytic syndrome

, , , , , , , & show all
Article: 2247887 | Received 14 Mar 2023, Accepted 10 Aug 2023, Published online: 18 Aug 2023

References

  • Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49.
  • Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.
  • Shibata S, Arima H, Asayama K, et al. Hypertension and related diseases in the era of COVID-19:a report from the Japanese society of hypertension task force on COVID-19. Hypertens Res. 2020;43(10):1028–1046.
  • Chee YJ, Tan SK, Yeoh E. Dissecting the interaction between COVID-19 and diabetes mellitus. J Diabetes Investig. 2020;11(5):1104–1114.
  • Meng L, Yang Y, Hu X, et al. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med. 2023;21(1):79. doi:10.1186/s12967-023-03924-y
  • Liu XC, Jiang YP, Sun XG, et al. Prognostic significance of the systemic immune-inflammation index in patients with cholangiocarcinoma: a meta-analysis. Front Oncol. 2022;12:938549.
  • Zhou Y, Dai M, Zhang Z. Prognostic significance of the systemic immune-inflammation index (SII) in patients with small cell lung cancer: a meta-analysis. Front Oncol. 2022;12:814727.
  • Lehmberg K, Nichols KE, Henter JI, et al. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica. 2015;100(8):997–1004.
  • Yoon JH, Park SS, Jeon YW, et al. Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy. Haematologica. 2019;104(2):269–276. doi:10.3324/haematol.2018.198655
  • Lin M, Park S, Hayden A, et al. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Ann Hematol. 2017;96(8):1241–1251. doi:10.1007/s00277-017-2993-y
  • Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–2914. doi:10.1182/blood-2015-01-551622
  • Zhuo WB, Gao Y, Yang CY, et al. Clinical characteristics of hemophagocytic syndrome: analysis of 46 cases. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(6):769, -inside back cover.
  • Schram AM, Campigotto F, Mullally A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125(10):1548–1552. doi:10.1182/blood-2014-10-602607
  • Janka GE, Lehmberg K. Hemophagocytic syndromes–an update. Blood Rev. 2014;28(4):135–142.
  • Jing H, Liqiong W, Xiaohua H, et al. Clinical etiology and prognosis of hemophagocyticlymphohistiocytosis: 56 cases and literature review. J Chongqing Med Univ. 2022;47(9):1104–1110.
  • Brito-Zerón P, Kostov B, Moral-Moral P, et al. Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis. Mayo Clin Proc Innov Qual Outcomes. 2018;2(3):267–276. doi:10.1016/j.mayocpiqo.2018.06.006
  • Brastianos PK, Swanson JW, Torbenson M, et al. Tuberculosis-associated haemopha-gocytic syndrome. Lancet Infect Dis. 2006;6(7):447–454.